ASHLEY ADAMS: Open Payments
NPI 1679935977 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 5 payments from 4 companies in 2025. Trend: 2023 $542 · 2024 $562 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $244 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| ACADIA Pharmaceuticals Inc | 1 | $22 |
| ABBVIE INC. | 1 | $22 |
Products named: REXULTI, INGREZZA, NUPLAZID, VRAYLAR.
Industry payments across AL — which companies pay providers there.
